Number of shares and voting rights as at 30 September 2014
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)
30.09.2014
Total number of outstanding shares forming the capital
9,194,111 ordinary shares under ISIN FR0000054694
822 shares issued from stock-options under ISIN FR0000054694
9,194,933
Number of shares with double voting rights
870,986
Total number of gross voting rights
10,065,919
Number of shares without voting rights
11,433 bearer shares in the frame of the liquidity contract
11,433
Total number of exercisable voting rights*
10,054,486
*Real number of voting rights = total number of voting rights – number of shares without voting rights
If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com
Financial schedule
- 2014 third-quarter sales
- 2014 third-quarter results
- Annual revenue
- Annual results
4 November 2014
28 November 2014
3 February 2015
31 March 2015
Upcoming events
- ACTIONARIA Show (Paris)
21-22 November 2014
Naturex has been listed since October 1996 on Euronext in Paris, Segment B
Total number of shares comprising the share capital: 9,194,933 (September 2014)
ISIN FR0000054694
NATUREX is a component of the CAC®PME, CAC Small and Gaïa indexes.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
Contacts
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Thierry-Bertrand Lambert
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
t.b.lambert@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Information relative au nombre total de droits de vote et d'actions composant le capital :
-
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-37448-2014.10.06-Nb-of-shares-and-voting-rights_September-2014.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews